Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Pfizer
(NY:
PFE
)
29.22
-0.05 (-0.17%)
Official Closing Price
Updated: 7:00 PM EDT, Oct 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Pfizer
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
34
35
Next >
Pfizer and Sanofi shares fall, which one to scoop up?
November 07, 2023
Pharmaceutical stocks aren't having a banner year; notably, two large pharmaceutical companies recently plunged to 52-week lows
Via
MarketBeat
Exposures
COVID-19
NetworkNewsAudio – Lexaria Bioscience Corp. (NASDAQ: LEXX) Evaluating Impact of Exclusive Drug-Delivery Solution on GLP-1 Drugs
November 03, 2023
Via
Investor Brand Network
Topics
Intellectual Property
Exposures
Intellectual Property
Pfizer Highlights Scientific Advances from Growing Hematology Portfolio at American Society of Hematology Annual Meeting
November 02, 2023
From
Pfizer Inc.
Via
Business Wire
Pfizer Inc. (NYSE: PFE) Near Top of Volume Charts in Monday Trading
October 16, 2023
Via
Investor Brand Network
Exposures
COVID-19
Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference
November 02, 2023
From
Pfizer Inc.
Via
Business Wire
Investor patience tested as pharmaceutical stocks take a tumble
November 01, 2023
The healthcare sector faces a selloff as pharmaceutical giants report lackluster earnings; even Amgen's strong results failed to prevent selling in the sector
Via
MarketBeat
Pfizer Reports Third-Quarter 2023 Results
October 31, 2023
From
Pfizer Inc.
Via
Business Wire
Can Diabetes, Weight-Loss Drugs Get Even Better?
October 30, 2023
Via
Investor Brand Network
Can Diabetes, Weight-Loss Drugs Get Even Better?
October 30, 2023
EQNX::TICKER_START (NASDAQ:LEXX,NYSE:NVO:NYSE:PFE,NYSE:MRK,NASDAQ:AZN) EQNX::TICKER_END
Via
FinancialNewsMedia
Acurx Pharmaceuticals Share Price And Volume Are Surging Ahead Of Phase 2b Trial Data Release ($ACXP)
October 27, 2023
Via
AB Newswire
Topics
Death
Exposures
Death
Pfizer and BioNTech Announce Positive Topline Data for mRNA-based Combination Vaccine Program Against Influenza and COVID-19
October 26, 2023
From
Pfizer Inc.
Via
Business Wire
Zenith Epigenetics Ltd. Announces Collaboration with Cencora on ZEN-3694
October 25, 2023
Calgary, Alberta--(Newsfile Corp. - October 25, 2023) - Zenith Epigenetics Ltd. ("Zenith" or the "Company"), a global leader in epigenetics,...
Via
Newsfile
Why the Relapsed/Refractory Acute Myeloid Leukemia Market is Expected to Witness Revolutionary Developments
October 24, 2023
EQNX::TICKER_START (NASDAQ:TCBP),(NYSE:CVM),(NASDAQ:INVO),(NASDAQ:SNY),(NYSE:PFE) EQNX::TICKER_END
Via
FinancialNewsMedia
Exposures
Product Safety
FDA Approves PENBRAYA™, the First and Only Vaccine for the Prevention of the Five Most Common Serogroups Causing Meningococcal Disease in Adolescents
October 20, 2023
From
Pfizer Inc.
Via
Business Wire
Atrial Fibrillation Drugs Market Rewriting Long Term Growth Story: Pfizer, GlaxoSmithKline, Sanofi
October 18, 2023
The Global Atrial Fibrillation Drugs Market has witnessed continuous growth in the past few years and may grow further during the forecast period (2023-2029). The market Study is segmented by key a...
Via
SBWire
Bristol Myers Squibb Joins Big Pharma’s Race to Dominate Oncology
October 17, 2023
Leading pharmaceutical companies are diving headfirst into oncology, sparking a buzz in the cancer treatment world. Bristol Myers Squibb is the latest company to join the movement, announcing its plan...
Via
PressReach
Arvinas and Pfizer Announce Upcoming Vepdegestrant (ARV-471) Poster Presentation at ESMO Congress 2023
October 15, 2023
From
Arvinas Inc.
Via
GlobeNewswire
Pfizer Amends U.S. Government Paxlovid Supply Agreement and Updates Full-Year 2023 Guidance
October 13, 2023
From
Pfizer Inc.
Via
Business Wire
U.S. FDA Approves Pfizer’s VELSIPITY™ for Adults with Moderately to Severely Active Ulcerative Colitis (UC)
October 13, 2023
From
Pfizer Inc.
Via
Business Wire
U.S. FDA Approves Pfizer’s BRAFTOVI® + MEKTOVI® for BRAF V600E-Mutant Metastatic Non-Small Cell Lung Cancer
October 12, 2023
From
Pfizer Inc.
Via
Business Wire
Antiparasitic Drugs Market to See Major Growth by 2023-2030 : Arbor Pharmaceuticals, GlaxoSmithKline, Cipla
October 11, 2023
Get an extensive Antiparasitic Drugs Market analysis of the dominant vendors, their latest products and services, and the competitive landscape of the industry.
Via
SBWire
Young Adults and Pancreatic Cancer: What the 80% Rise in Diagnoses Means for Future Treatment
October 11, 2023
EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:GNLX),(NASDAQ:CRNX),(NYSE:PFE),(NASDAQ:SGEN) EQNX::TICKER_END
Via
FinancialNewsMedia
Steroids Market Is Set to Fly High in Years to Come : Pfizer, Johnson & Johnson, Bayer
October 10, 2023
Stay up to date with Steroids Market research offered by HTF MI. Check how key trends and emerging drivers are shaping this industry growth.
Via
SBWire
Cancer Immunotherapies Market Set for More Growth : American Cancer Society, WebMD, Eli Lily and Company
October 10, 2023
Get an extensive Cancer Immunotherapies Market analysis of the dominant vendors, their latest products and services, and the competitive landscape of the industry.
Via
SBWire
Elli Lilly Joins Big Pharma’s Multi-Billion-Dollar Oncology Race
October 10, 2023
Large pharmaceutical companies are increasingly investing in cancer treatment stocks, driven by the promise of medical breakthroughs and financial rewards. Eli Lilly became the latest Big Pharma giant...
Via
PressReach
Big Pharma’s Billion-Dollar Bets on Advanced Cancer Therapies
October 10, 2023
Big Pharma is continuing its oncology buying spree, with a flurry of multi-billion-dollar deals, partnerships, and investments creating a buzz in the cancer treatment space. American pharmaceutical...
Via
PressReach
Exposures
COVID-19
Pfizer Presents New Data at IDWeek 2023 Highlighting Advances in Prevention and Treatment of Certain Respiratory Illnesses and Other Infectious Diseases
October 05, 2023
From
Pfizer Inc.
Via
Business Wire
Pfizer Declares Fourth-Quarter 2023 Dividend
October 04, 2023
From
Pfizer Inc.
Via
Business Wire
5 Stocks That Have Massive Upside According to Analysts
September 28, 2023
Analyst ratings are frequently a solid predictor of future stock price movement; here are five stocks that analysts believe have massive upside.
Via
MarketBeat
Kevin Dodelande's iMi launches into early cancer detection
September 28, 2023
In this age of technological advances, the power of Big Data combined with Artificial Intelligence (AI) is opening up new possibilities through early diagnosis to increase patient life expectancy.
Via
IssueWire
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
34
35
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.